J&J Covid vaccine recipients are better off getting Pfizer or Moderna booster, NIH study suggests
[ad_1]
The Pfizer BioNTech Covid-19 vaccines will be available at the Worcester Senior Living Facility in Pennsylvania on Wednesday, August 25, 2021.
Bloomberg – Getty Images| Bloomberg | Getty Images
Johnson & JohnsonThe best option for Covid-19 vaccination recipients is to get a booster shot from Moderna or Pfizer, according to a U.S. study that was published Wednesday.
The study on “mixing and matching” Covid vaccines included more than 450 adults who have received one of the three regimens currently available in the United States: J&J’s, Moderna’s or Pfizer’s. However, the study was not peer reviewed.
This is an ongoing story. Keep checking back for more updates.
[ad_2]